Monopar Therapeutics Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on events occurring on June 30, 2021, specifically the 2021 Annual Meeting of Stockholders for Monopar Therapeutics Inc. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol MNPR. The filing details the outcomes of three proposals submitted to stockholders.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are typically found in periodic reports such as Form 10-K or 10-Q.
Material Changes and Voting Results
As of the record date (May 3, 2021), 12,569,932.614 shares were entitled to vote. A total of 9,766,313.384 shares were represented at the meeting. The following proposals were approved:
- Election of Directors: Six directors were elected to serve until the next annual meeting. All nominees received significant "For" votes, with Christopher M. Starr, Ph.D. receiving the highest support (8,366,264.384 votes).
- Ratification of Auditors: Stockholders ratified the selection of BPM LLP as the independent registered public accounting firm for the year ending December 31, 2021. The proposal passed with 9,740,948.384 votes "For".
- Amendment to 2016 Stock Incentive Plan: Stockholders approved an amendment to the 2016 Stock Incentive Plan. Key changes include removing certain individual award limits, updating provisions related to I.R.C. Section 162(m), and updating the limit on Incentive Stock Options. The proposal passed with 8,212,529.284 votes "For".
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific business risks. The document focuses strictly on the administrative results of the Annual Meeting. The company is identified as an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Key Facts for Investor Verification
- Verify the specific terms of the amended 2016 Stock Incentive Plan in the definitive proxy statement filed on April 30, 2021.
- Confirm the tenure of the newly elected board members, who serve until the next annual meeting.
- Note that BPM LLP is the confirmed auditor for the fiscal year ending December 31, 2021.
- Review subsequent 10-Q or 10-K filings for actual financial performance data, as this 8-K contains none.